Our subsequent study corroborated this conclusion by showing that the presence of PPARγ antagonist reversed in vitro and in vivo effects of genipin, suggesting the core role PPARγ in mediating the inhibiting effect of genipin on postoperative HCC recurrence. Here, PPARG is linked to hepatocellular carcinoma.